98 related articles for article (PubMed ID: 25829971)
1. Somatic cancer mutations in the MLL3-SET domain alter the catalytic properties of the enzyme.
Weirich S; Kudithipudi S; Kycia I; Jeltsch A
Clin Epigenetics; 2015; 7(1):36. PubMed ID: 25829971
[TBL] [Abstract][Full Text] [Related]
2. Somatic mutations of the mixed-lineage leukemia 3 (MLL3) gene in primary breast cancers.
Wang XX; Fu L; Li X; Wu X; Zhu Z; Fu L; Dong JT
Pathol Oncol Res; 2011 Jun; 17(2):429-33. PubMed ID: 21116761
[TBL] [Abstract][Full Text] [Related]
3. MLL3/MLL4 enzymatic activity shapes DNA replication timing.
Gökbuget D; Boileau RM; Lenshoek K; Blelloch R
bioRxiv; 2023 Dec; ():. PubMed ID: 38106216
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic targeting of metabolic vulnerabilities in cancers with MLL3/4-COMPASS epigenetic regulator mutations.
Zhao Z; Cao K; Watanabe J; Philips CN; Zeidner JM; Ishi Y; Wang Q; Gold SR; Junkins K; Bartom ET; Yue F; Chandel NS; Hashizume R; Ben-Sahra I; Shilatifard A
J Clin Invest; 2023 Jul; 133(13):. PubMed ID: 37252797
[TBL] [Abstract][Full Text] [Related]
5. Pax6 associates with H3K4-specific histone methyltransferases Mll1, Mll2, and Set1a and regulates H3K4 methylation at promoters and enhancers.
Sun J; Zhao Y; McGreal R; Cohen-Tayar Y; Rockowitz S; Wilczek C; Ashery-Padan R; Shechter D; Zheng D; Cvekl A
Epigenetics Chromatin; 2016; 9(1):37. PubMed ID: 27617035
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics explorations of active site structure in designed and evolved enzymes.
Osuna S; Jiménez-Osés G; Noey EL; Houk KN
Acc Chem Res; 2015 Apr; 48(4):1080-9. PubMed ID: 25738880
[TBL] [Abstract][Full Text] [Related]
7. Crucial roles of mixed-lineage leukemia 3 and 4 as epigenetic switches of the hepatic circadian clock controlling bile acid homeostasis in mice.
Kim DH; Rhee JC; Yeo S; Shen R; Lee SK; Lee JW; Lee S
Hepatology; 2015 Mar; 61(3):1012-23. PubMed ID: 25346535
[TBL] [Abstract][Full Text] [Related]
8. Evidence for communality in the primary determinants of CYP74 catalysis and of structural similarities between CYP74 and classical mammalian P450 enzymes.
Hughes RK; Yousafzai FK; Ashton R; Chechetkin IR; Fairhurst SA; Hamberg M; Casey R
Proteins; 2008 Sep; 72(4):1199-211. PubMed ID: 18338380
[TBL] [Abstract][Full Text] [Related]
9. Somatic cancer mutations in the DNMT2 tRNA methyltransferase alter its catalytic properties.
Elhardt W; Shanmugam R; Jurkowski TP; Jeltsch A
Biochimie; 2015 May; 112():66-72. PubMed ID: 25747896
[TBL] [Abstract][Full Text] [Related]
10. Smyd3 open & closed lock mechanism for substrate recruitment: The hinge motion of C-terminal domain inferred from μ-second molecular dynamics simulations.
Chandramouli B; Silvestri V; Scarno M; Ottini L; Chillemi G
Biochim Biophys Acta; 2016 Jul; 1860(7):1466-74. PubMed ID: 27085704
[TBL] [Abstract][Full Text] [Related]
11. Structural insight into autoinhibition and histone H3-induced activation of DNMT3A.
Guo X; Wang L; Li J; Ding Z; Xiao J; Yin X; He S; Shi P; Dong L; Li G; Tian C; Wang J; Cong Y; Xu Y
Nature; 2015 Jan; 517(7536):640-4. PubMed ID: 25383530
[TBL] [Abstract][Full Text] [Related]
12. Characterization and expression analysis during embryo development of the mouse ortholog of MLL3.
Brun ME; Gasca S; Girard C; Bouton K; De Massy B; De Sario A
Gene; 2006 Apr; 371(1):25-33. PubMed ID: 16459028
[TBL] [Abstract][Full Text] [Related]
13. 6 Structure of SET domain protein lysine methyltransferases.
Xiao B; Gamblin SJ; Wilson JR
Enzymes; 2006; 24():155-78. PubMed ID: 26718040
[TBL] [Abstract][Full Text] [Related]
14. Distributions of enzyme residues yielding mutants with improved substrate specificities from two different directed evolution strategies.
Paramesvaran J; Hibbert EG; Russell AJ; Dalby PA
Protein Eng Des Sel; 2009 Jul; 22(7):401-11. PubMed ID: 19502357
[TBL] [Abstract][Full Text] [Related]
15. Cancer-Associated Mutations in Breast Tumor Kinase/PTK6 Differentially Affect Enzyme Activity and Substrate Recognition.
Tsui T; Miller WT
Biochemistry; 2015 May; 54(20):3173-82. PubMed ID: 25940761
[TBL] [Abstract][Full Text] [Related]
16. Cis-regulatory somatic mutations and gene-expression alteration in B-cell lymphomas.
Mathelier A; Lefebvre C; Zhang AW; Arenillas DJ; Ding J; Wasserman WW; Shah SP
Genome Biol; 2015 Apr; 16(1):84. PubMed ID: 25903198
[TBL] [Abstract][Full Text] [Related]
17. Enzyme-dependent lysine deprotonation in EZH2 catalysis.
Kipp DR; Quinn CM; Fortin PD
Biochemistry; 2013 Oct; 52(39):6866-78. PubMed ID: 24000826
[TBL] [Abstract][Full Text] [Related]
18. Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma.
Balakrishnan A; Bleeker FE; Lamba S; Rodolfo M; Daniotti M; Scarpa A; van Tilborg AA; Leenstra S; Zanon C; Bardelli A
Cancer Res; 2007 Apr; 67(8):3545-50. PubMed ID: 17440062
[TBL] [Abstract][Full Text] [Related]
19. Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development.
Bianco-Miotto T; Chiam K; Buchanan G; Jindal S; Day TK; Thomas M; Pickering MA; O'Loughlin MA; Ryan NK; Raymond WA; Horvath LG; Kench JG; Stricker PD; Marshall VR; Sutherland RL; Henshall SM; Gerald WL; Scher HI; Risbridger GP; Clements JA; Butler LM; Tilley WD; Horsfall DJ; Ricciardelli C;
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2611-22. PubMed ID: 20841388
[TBL] [Abstract][Full Text] [Related]
20. Probing the catalytic mechanism of GDP-4-keto-6-deoxy-d-mannose Epimerase/Reductase by kinetic and crystallographic characterization of site-specific mutants.
Rosano C; Bisso A; Izzo G; Tonetti M; Sturla L; De Flora A; Bolognesi M
J Mol Biol; 2000 Oct; 303(1):77-91. PubMed ID: 11021971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
